NCT04309708View on ClinicalTrials.gov

Efficacy and Safety Assessment for a New UV-protected Pump Infusion Line in Intravenous Infusion Therapy

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

September 6, 2019

Study Completion Date

September 8, 2019

Conditions
Subarachnoid Hemorrhage
Interventions
DEVICE

Nimodipine pump infusion

Patients with nimodipine pump infusion with pump infusion line and other infusion equipments

Trial Locations (5)

100000

Xuanwu Hospital, Capital Medical University, Beijing

100070

Beijing Tiantan Hospital, Capital Medical University, Beijing

100093

Sanbo Brain Hospital, Captial Medical University, Beijing

300052

Tianjin Medical University General Hospital, Tianjin

050000

The Second Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

B. Braun Medical International Trading Company Ltd.

INDUSTRY

NCT04309708 - Efficacy and Safety Assessment for a New UV-protected Pump Infusion Line in Intravenous Infusion Therapy | Biotech Hunter | Biotech Hunter